Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-01-22 00:00:00 ET · period of report 2025-01-17 · accession 0001805688-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 2025-01-17 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | F - Tax | $122.62 | -13.8K | 441.2K | -3% | -$1.70M | |
| 2025-01-22 | 2025-01-17 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | A - Grant | $0.00 | +29.6K | 455.1K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-01-17 | F | D | 13,840 | $122.62 | 441,244 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-01-17 | A | A | 29,559 | $0.00 | 455,084 | D | — | — |